DE69130068T2 - Humane rotativen, impfstoffe und methoden - Google Patents

Humane rotativen, impfstoffe und methoden

Info

Publication number
DE69130068T2
DE69130068T2 DE69130068T DE69130068T DE69130068T2 DE 69130068 T2 DE69130068 T2 DE 69130068T2 DE 69130068 T DE69130068 T DE 69130068T DE 69130068 T DE69130068 T DE 69130068T DE 69130068 T2 DE69130068 T2 DE 69130068T2
Authority
DE
Germany
Prior art keywords
hrv
human
novel
rotaviruses
disclosed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69130068T
Other languages
English (en)
Other versions
DE69130068D1 (de
Inventor
Richard Ward
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cincinnati Childrens Hospital Medical Center
Original Assignee
Cincinnati Childrens Hospital Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cincinnati Childrens Hospital Medical Center filed Critical Cincinnati Childrens Hospital Medical Center
Publication of DE69130068D1 publication Critical patent/DE69130068D1/de
Application granted granted Critical
Publication of DE69130068T2 publication Critical patent/DE69130068T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/15—Reoviridae, e.g. calf diarrhea virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12311—Rotavirus, e.g. rotavirus A
    • C12N2720/12321—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12311—Rotavirus, e.g. rotavirus A
    • C12N2720/12334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DE69130068T 1990-11-16 1991-11-04 Humane rotativen, impfstoffe und methoden Expired - Lifetime DE69130068T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61431090A 1990-11-16 1990-11-16
PCT/US1991/008191 WO1992008786A1 (en) 1990-11-16 1991-11-04 Human rotaviruses, vaccines and methods

Publications (2)

Publication Number Publication Date
DE69130068D1 DE69130068D1 (de) 1998-10-01
DE69130068T2 true DE69130068T2 (de) 1999-01-07

Family

ID=24460695

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69130068T Expired - Lifetime DE69130068T2 (de) 1990-11-16 1991-11-04 Humane rotativen, impfstoffe und methoden

Country Status (13)

Country Link
US (2) US5474773A (de)
EP (1) EP0557427B1 (de)
JP (1) JP2753393B2 (de)
KR (1) KR0171434B1 (de)
AT (1) ATE170081T1 (de)
AU (2) AU9060391A (de)
BR (1) BR9106982A (de)
CA (1) CA2096315C (de)
DE (1) DE69130068T2 (de)
DK (1) DK0557427T3 (de)
ES (1) ES2121841T3 (de)
GR (1) GR3027744T3 (de)
WO (1) WO1992008786A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5626851A (en) * 1987-11-30 1997-05-06 The Wistar Institute Of Anatomy And Biology Rotavirus reassortant vaccine
US5610049A (en) * 1991-05-01 1997-03-11 The Wistar Institute Of Anatomy And Biology Human rotavirus HCR3A and method of growing said rotavirus
US6780630B1 (en) * 1992-07-10 2004-08-24 Baylor College Of Medicine Parenteral immunization against rotavirus
US5773009A (en) * 1994-04-15 1998-06-30 The United States Of America As Represented By The Department Of Health And Human Services Rotavirus strain G9P11
WO1996001651A1 (en) * 1994-07-11 1996-01-25 The Government Of The United States Of America, Represented By The Department Of Health And Human Services Attenuated human rotavirus vaccine
US6673355B1 (en) 1995-06-14 2004-01-06 Baylor College Of Medicine Rotavirus enterotoxin NSP4 and methods of using same
AU6387196A (en) 1995-06-14 1997-01-15 Baylor College Of Medicine Rotavirus enterotoxin nsp4 and methods of using same
KR19990072201A (ko) * 1996-10-18 1999-09-27 무타이 마사히꼬 로타바이러스 항원, 로타바이러스 감염증에 대한백신 및 진단제와 항원 제조방법
US6589529B1 (en) * 1998-10-30 2003-07-08 Children's Hospital Medical Center Rotavirus subunit vaccine
CZ302173B6 (cs) * 1999-08-17 2010-11-24 Smithkline Beecham Biologicals S. A. Oslabená populace lidského rotaviru
GB9919468D0 (en) 1999-08-17 1999-10-20 Smithkline Beecham Biolog Vaccine
KR100305188B1 (ko) * 2000-12-26 2001-09-24 정동혁 로타바이러스에 대한 백신
GB0414787D0 (en) * 2004-07-01 2004-08-04 Glaxosmithkline Biolog Sa Method
CN100448485C (zh) * 2003-09-02 2009-01-07 葛兰素史密丝克莱恩生物有限公司 疫苗
MXPA06002459A (es) * 2003-09-02 2006-06-20 Glaxosmithkline Biolog Sa Vacuna.
GB0503337D0 (en) * 2005-02-17 2005-03-23 Glaxosmithkline Biolog Sa Compositions
US20090028828A1 (en) * 2005-08-17 2009-01-29 Glaxosmithkline Biologicals Sa Rotavirus Vaccine Inducing Heterotypic Cross Protection
ES2723776T3 (es) 2009-05-12 2019-09-02 The Government Of The Us Secretary Department Of Health And Human Services Nuevas cepas de rotavirus humano y vacunas
TR201802091T4 (tr) 2012-05-11 2018-03-21 Medicago Inc Bitkilerde rotavirüs - benzeri partikül üretimi.
CA2974438A1 (en) 2015-01-23 2016-07-28 Medicago Inc. Rotavirus-like particle production in plants
GB201614799D0 (en) 2016-09-01 2016-10-19 Glaxosmithkline Biologicals Sa Compositions
CN117737005B (zh) * 2024-01-31 2024-05-14 金宇保灵生物药品有限公司 一株猪轮状病毒毒株及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4341870A (en) * 1980-11-19 1982-07-27 The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Cultivatable human rotavirus type 2
US4341763A (en) * 1981-03-10 1982-07-27 Smithkline-Rit Methods of vaccinating humans against rotavirus infection
US4571385A (en) * 1983-06-27 1986-02-18 The United States Of America As Represented By The Department Of Health And Human Services Genetic reassortment of rotaviruses for production of vaccines and vaccine precursors
EP0152295B1 (de) * 1984-02-09 1991-03-20 Royal Children's Hospital Research Foundation Lebender attenuierter menschlicher Rotavirus-Impfstoff und Herstellung desselben
US4636385A (en) * 1985-02-15 1987-01-13 The Wistar Institute Of Anatomy & Biology Vaccine, method for its preparation, and use thereof in vaccinating humans against rotavirus infection
US4853333A (en) * 1985-07-26 1989-08-01 American Home Products Corporation Production of rotavirus in yeast
US4751080A (en) * 1985-08-26 1988-06-14 The United States Of America As Represented By The Department Of Health And Human Services Vaccine against rotavirus diseases
US4927628A (en) * 1987-09-21 1990-05-22 The United States Of America As Represented By The Department Of Health And Human Services Vaccine against rotavirus diseases and method of preparing same
WO1989006971A1 (en) * 1988-02-01 1989-08-10 The Board Of Trustees Of The Leland Stanford Junio Conserved rotavirus gene segments and use in immunization and neutralization

Also Published As

Publication number Publication date
EP0557427A4 (de) 1995-01-25
EP0557427B1 (de) 1998-08-26
AU3787795A (en) 1996-02-29
DK0557427T3 (da) 1998-10-26
AU702044B2 (en) 1999-02-11
DE69130068D1 (de) 1998-10-01
AU9060391A (en) 1992-06-11
BR9106982A (pt) 1993-08-31
US5695767A (en) 1997-12-09
GR3027744T3 (en) 1998-11-30
ATE170081T1 (de) 1998-09-15
ES2121841T3 (es) 1998-12-16
JP2753393B2 (ja) 1998-05-20
US5474773A (en) 1995-12-12
JPH06505964A (ja) 1994-07-07
WO1992008786A1 (en) 1992-05-29
KR0171434B1 (ko) 1999-02-01
CA2096315A1 (fr) 1992-05-17
EP0557427A1 (de) 1993-09-01
CA2096315C (en) 1996-11-19

Similar Documents

Publication Publication Date Title
DE69130068D1 (de) Humane rotativen, impfstoffe und methoden
Fekadu et al. Efficacy of rabies vaccines against Duvenhage virus isolated from European house bats (Eptesicus serotinus), classic rabies and rabies-related viruses
DK0755259T3 (da) Kimære-cDNA-kloner af virussen for den infektiöse GUMBORO-syge, ekspressionsprodukter heraf og vacciner baseret derpå
US20060193874A1 (en) Vaccines for proliferative ileitis and methods of making and using the same
EP0192404A3 (de) Impfstoff, Verfahren zur Herstellung desselben und seine Anwendung für die Impfung von Menschen gegen eine Rotavirus-Infektion
Charlton et al. Skunk rabies
NO904538D0 (no) Kimaere glykoproteiner inneholdende immunogene segmenter av humant parainfluensavirus type 3.
DE2967036D1 (en) Vaccine and method of making
NL300252I2 (nl) Rotavirus-reassortanten-vaccin.
Lee et al. Immunological response to recombinant VP8* subunit protein of bovine rotavirus in pregnant cattle
DK167599B1 (da) Vaccine til beskyttelse af heste mod kvaerke foraarsaget af streptococcus equi, fremgangsmaade til fremstilling af en stamme af s. equi, som er avirulent for heste, samt s. equi-stamme
EP0498804A1 (de) Verfahren zur herstellung von impfstoffen oder toxoiden und immunisierung durch behandlung mit rekombinanten mikroorganismen.
ATE285791T1 (de) Impfstoff, der acemannan als adjuvans enthält
DK0493575T3 (da) Vaccine af reassortant rotavirus
Ward Human rotaviruses, vaccines and method
DK170393B1 (da) Avirulent rabies-vaccine samt avirulent mutant af stammen SAD Berne
Yoo et al. Maternal immunization of pregnant cattle with recombinant VP8* protein of bovine rotavirus elicits neutralizing antibodies to multiple serotypes: colostral neutralizing antibody by rotavirus VP8
DE3109696A1 (de) Verfahren zur herstellung eines als impfstoff geeigneten synthetischen peptids und es enthaltender impfstoff
IE40159L (en) Vaccine for marek's disease.
EKUE EPIDEMIOLOGY OF AFRICAN SWINE FEVER IN CAMEROON (SWINE FEVER)
KR850004398A (ko) 가와사끼병 처리용 왁진, 항원 및 항체
Hyllseth et al. Cross Neutralization of Maedi‐Visna Virus Strains

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8380 Miscellaneous part iii

Free format text: DINGLICHES RECHT WURDE BESTELLT